Understanding the biological success of SARS-CoV-2: Immunoevasion strategies and beyond
- PMID: 37277247
- PMCID: PMC10235673
- DOI: 10.1016/j.ejim.2023.05.033
Understanding the biological success of SARS-CoV-2: Immunoevasion strategies and beyond
Conflict of interest statement
Declaration of Competing Interest All authors have no actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.
Figures
Comment on
-
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster.Nat Med. 2023 Feb;29(2):344-347. doi: 10.1038/s41591-022-02162-x. Epub 2022 Dec 6. Nat Med. 2023. PMID: 36473500
References
-
- McVernon J., Liberman J. WHO keeps covid-19 a public health emergency of international concern. BMJ. 2023;380:504. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous